Vontobel Holding Ltd. Exelixis, Inc. Transaction History

Vontobel Holding Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$17.03 - $22.67 $210,082 - $279,657	-12,336 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $195,402 - $269,911	12,336 New	12,336 $230,000
Q1 2021 May 11, 2021	SELL	$20.53 - $25.22 $374,672 - $460,265	-18,250 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $335,617 - $452,600	18,250 New	18,250 $435,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.